NDC 50090-1606

Triumeq

Abacavir Sulfate, Dolutegravir Sodium, Lamivudine

Triumeq is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Abacavir Sulfate; Dolutegravir Sodium; Lamivudine.

Product ID50090-1606_37a43c59-6382-40e8-9a5b-cc9d0e01122d
NDC50090-1606
Product TypeHuman Prescription Drug
Proprietary NameTriumeq
Generic NameAbacavir Sulfate, Dolutegravir Sodium, Lamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-08-22
Marketing CategoryNDA / NDA
Application NumberNDA205551
Labeler NameA-S Medication Solutions
Substance NameABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
Active Ingredient Strength600 mg/1; mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50090-1606-0

30 TABLET, FILM COATED in 1 BOTTLE (50090-1606-0)
Marketing Start Date2015-01-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-1606-0 [50090160600]

Triumeq TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205551
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-01-07
Marketing End Date2019-03-31

Drug Details

Active Ingredients

IngredientStrength
ABACAVIR SULFATE600 mg/1

Pharmacological Class

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • HIV Integrase Inhibitors [MoA]
  • Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
  • Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC Crossover Matching brand name "Triumeq" or generic name "Abacavir Sulfate, Dolutegravir Sodium, Lamivudine"

NDCBrand NameGeneric Name
49702-231Triumeqabacavir sulfate, dolutegravir sodium, lamivudine
50090-1606Triumeqabacavir sulfate, dolutegravir sodium, lamivudine
49702-258Triumeq PDabacavir sulfate, dolutegravir sodium, lamivudine

Trademark Results [Triumeq]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRIUMEQ
TRIUMEQ
77650550 4000175 Live/Registered
VIIV HEALTHCARE COMPANY
2009-01-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.